<DOC>
	<DOCNO>NCT01114126</DOCNO>
	<brief_summary>The primary objective study evaluate safety tolerability Neu-P11 , follow administration multiple ascend oral dos ( 2 , 5 , 20 , 50 mg match placebo ) give nightly 2 period 5 day male female subject primary insomnia . In addition , study aim determine pharmacokinetic profile Neu-P11 1 5 day administration evaluate hypnotic effect Neu-P11 well effect mood memory . The study hypothesis Neu-P11 safe , tolerate significant sleep promoting effect .</brief_summary>
	<brief_title>Safety , Tolerability , Pharmacokinetics Pharmacodynamics Neu-P11 Subjects With Primary Insomnia</brief_title>
	<detailed_description>The effect four multiple ascend dos orally administer Neu-P11 evaluate double- blind , placebo-controlled , crossover design . Following screen visit , recruit subject undergo inclusion/habituation full night PSG screen record sleep clinic exclude subject sleep disorder . Eligible subject divide 2 cohort 12 subject . Following screening , cohort randomise receive Neu-P11 placebo first period 5 day cross follow least 21 day receive placebo high dose Neu-P11 second period 5 day . Each cohort receive different dose Neu-P11 , choose 2 , 5 , 20 50 mg . The start dose 5 mg small dose ( 2 mg ) also include purpose pharmacodynamic evaluation . Before proceed 5mg next high dose safety evaluate base adverse event , clinical biological data . Subjects Cohort A randomise dose level 2 3 ( dos 5 20 mg ) . Subjects Cohort B randomise dose level 1 4 ( dos 2 50 mg ) .</detailed_description>
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<criteria>1 . Primary insomnia male female subject accord DSMIV criterion ( 307.42 ) , 2 . Sleep latency &gt; 30 minute total sleep time &lt; 6 hr base Sleep History Questionnaire ( SHQ ) verify inclusion + habituation night PSG , 3 . Men woman 18 65 year inclusive , 4 . Women childbearing potential must negative pregnancy test screen visit , Day 1 treatment period , use reliable method contraception entire study duration least 3 month study drug intake . Reliable method contraception : Double barrier type device ( e.g. , male female condom , diaphragm , contraceptive sponge ) combination spermicide . Intrauterine device combination spermicide . Abstention , rhythm method , contraception partner alone acceptable method contraception . Women childbearing potential define postmenopausal ( i.e. , amenorrhea least 1 year ) , surgically naturally sterile . 5 . Subjects must good health determine medical history , physical examination , ECG , vital sign , standard EEG , serum biochemistry , haematology urinalysis . A subject clinical abnormality may include investigator designee consider abnormality introduce additional risk factor subject 's health , interfere study objective , 6 . Subjects use BZD nonBZD hypnotic melatoninergic drug past 2 week prior Screening , 7 . Subjects use psychotropic treatment past 3 month prior screen , 8 . Subjects use nonpsychotropic treatment past 2 week prior Screening exception occasional paracetamol intake ( 1 g per day ) , 9 . Subjects read sign informed consent form , 10 . Subjects body mass index 18 30 ( extreme include ) , 11 . Subjects document hypersensitivity exogenous melatonin agonist , 12 . Subjects agree completely refrain alcohol , caffeine tobacco institutionalisation period , 13 . Subjects able take part whole study , 14 . Subjects affiliate , beneficiary , social security system 1 . According DSM IV , subject belong follow group exclude : 780.59 ( breathe relate sleep disorder ) ; 307.45 ( circadian rhythm sleep disorder ) ; 307.47 ( dyssomnia otherwise specify ) ; 780.xx ( sleep disorder due general medical condition ) , 2 . Subjects suffer insomnia secondary cause accord SHQ , 3 . Subjects sleep disorder detect PSG inclusion/habituation night , sleep apnea/hypopnea periodic leg movement syndrome ( arousal ) ( PLMI &gt; 15 and/or AHI &gt; 15 per hour ) , 4 . Subjects know chronic infection asthma , allergy history severe allergy , 5 . Subjects hypertension define systolic blood pressure &gt; 180 mmHg and/or diastolic blood pressure &gt; 100 mmHg accord two repeated measure lie position within 10 min interval , 6 . Subjects hypotension define systolic blood pressure &lt; 90 mmHg and/or diastolic blood pressure &lt; 45 mmHg accord two repeated measure lie position within 10 min interval , 7 . Subjects foreseeable need treatment , whatever ( include dental care ) , study period , 8 . Subjects positive drug screen amphetamine , benzodiazepine , barbiturate , cannabis , cocaine morphine/opiates , methadone , tricyclic , methamphetamine ( ecstasy ) codeine , suspect drug alcohol addict , 9 . Subjects positive serology human immunodeficiency virus antibody ( HIV Ab ) , 10 . Subjects positive Hepatitis B virus surface antigen ( HBs Ag ) hepatitis C virus antibody ( HCV Ab ) , 11 . Subjects previous ongoing chronic recurrent disease especially convulsive disorder central nervous system psychiatric disease , 12 . Subjects history pathology likely recur immediately study , 13 . Subjects significant cardiovascular , pulmonary , renal , hepatic , gastrointestinal , neurological , psychiatric , endocrine , cancer blood disease , 14 . Subjects take unstable treatment central effect within 90 day prior experiment , 15 . Subjects alcohol consumption 40 g alcohol per day , 16 . Subjects drink 6 cup coffee ( equivalent xanthinecontaining beverage ) per day , 17 . Subjects smoke 5 cigarette per day , 18 . Subjects know drug addiction , 19 . Subjects donate 300 ml blood within 90 day prior start study , 20 . Subjects exclusion period accord French National File Volunteers Participating Biomedical Research , 21 . Subjects earn total annual amount compensation participate clinical study exceed 4500 Euros ( include compensation study ) , 22 . Subjects legal incapacity limited legal capacity , 23 . Subjects likely , accord investigator 's opinion , cooperate respect constraint study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Neu-P11</keyword>
	<keyword>Insomnia</keyword>
	<keyword>PSG</keyword>
	<keyword>safety</keyword>
</DOC>